AI-developed drug rentosertib shows early anti-aging signals across six aging clocks
Dr_Singularity · x · 2026-09-07
A proteomic analysis of 42 patients found all six aging clocks moved toward younger predicted biological age in groups treated with rentosertib, an AI-assisted drug candidate originally developed for a rare lung condition, while the placebo group showed little change or slight increases. The drug's maker says it appears to reduce biological hallmarks of aging.
Related event: AI-Designed IPF Drug Rentosertib Shows Biological Age Reversal in Trial(18 posts)→
More from Research
- Token Collapse: Study Finds Graph Soft Prompting Tokens in LLMs Fail to Encode Structure — Sapienza · 2026-10-27
- Mathathon 2.0 launches with Terence Tao's SAIR, $1.5M in compute for teams — _sathvikr · 2026-10-27
- The 'sweet lesson' is real: two kinds of ML problems need opposite strategies — mike64_t · 2026-10-27
- PixGR: Pixel-space generative decoding for fast feed-forward 3D reconstruction — kwangmoo_yi · 2026-10-27
- UniAction: unified action conditioning lets one world model handle mixed action types — ZeYanjie · 2026-10-27
- Infini-AI Lab open-sources Hermit, a framework for agent harness evolution and continual learning — BeidiChen · 2026-10-27